Metabolic síndrome and erectile dysfunction;Síndrome metabólico y disfunción eréctil

Archivos Espanoles de Urologia

Volumn 63, Issue 8, 2010, Pages 673-678

  Navarrete, Remigio Vela ^a   Muñoz, Jesús Gómez ^a   Martín, Leticia López ^a   Cardoso, Juan Vicente García ^a   Enguita, Carmen González ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Androgen deficiency; Erectile dysfunction; Metabolic s ndrome

Indexed keywords

ARTICLE; ERECTILE DYSFUNCTION; HUMAN; MALE; METABOLIC SYNDROME X;

ERECTILE DYSFUNCTION; HUMANS; MALE; METABOLIC SYNDROME X;

EID: 78149251497     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. WHO consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. WHO/NCD/NCS/1999. 2; 31-33
2. Serrano Ríos, M. Síndrome metabólico. Tiempos médicos 2009 66 245-248
3. Alvarez EE, Ribas L, Serra L. Prevalencia del síndrome metabólico en la población de la Comunidad Canaria. Med Clin (Barc). 2003; 120: 172-174
4. Alegría E, Cordero A, Grima A, Casasnovas JA, Laclaustra M, Luengo E, et al.. Prevalencia del síndrome metabólico en población laboral española: Registro MESYAS. Rev Esp Cardiol. 2005;58:797-806.
5. Cordero A, Alegría E, León M. Prevalencia del síndrome metabólico. Rev Esp Cardiol. 2006; 5: 11-15.
6. Yassin, A.A.; Saad, F.; Gooren, L.J. Methabolic syndrome, testosterone deficiency and erectile disfunction never come alone. Andrología 2008 40; 4; 259-264
7. Reilly MP, Rader DJ.. The metabolic syndrome: more than the sum of it's parts? Circulation. 2003; 108: 1546-1551
8. Sáez ME, Grilo A, Morón Fj, Manzano L, González- Pérez A, Serrano-Hernando A, Ruiz A,Ramírez-Lorca R, Serrano-Ríos M. The peroxisome proliferator-activated receptor delta gene is associated with obesity and interacts with the calpain 5 gene to modulate the phenotype. Cardiovascular Diabetology 2008 Jul 25;7:23.
9. Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993;92:141-146
10. Ai A, Tanaka A, Ogita K, Sekine M, Numano F, Numano U, Reaven G. Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance. J Clin Endocrinol Metabol 2000; 85:3557-3560
11. Gimeno JA, Lou JM, Molinero E, Poned B, Portilla DP. Influencia del síndrome metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2. Rev Esp Cardiol 2004; 57: 507-513
12. Alexander CM, Landsman PB, Teutsch SM, Haffner SM.. NECP-Defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003; 52: 1210-1214
13. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: a 8-year follow-up of 14,719 initially healthy American women. Circulation. 2003; 107: 391-397
14. Tsujimura A, Takada S, Matsuoka Y, Nakayama J, Takao T, Miyagawa Y, Sonoda M, Nishizawa H, Iwahashi H, Funahashi T, Nonomura N, Okuyama A. Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link? Int J Urol. 2009 Oct; 16(10): 830-835
15. Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M.. Interactions between leptin and the human sympathetic nervous system. Hypertension. 2003; 41: 1072-1079
16. Chu NF, Spiegelman D. Plasma insulin, leptin and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atheros 678 clerosis 2001; 157: 495-503.
17. Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. JAndrol. 2009 Sep-Oct; 30(5): 477-494
18. Vela Navarrete, R.; Garcia Cardoso, J.V.; Pardo Montero, M.; Jimenez Mateos-Caceres, P.; Lopez Farré, A. Testosterona, función endotelial, salud cardiovascular y androgenodeficiencia del varón añoso. Arch. Esp. Urol. 2009; 62, 3; 173-178
19. Lopez Farré, A.; Macaya, C. Androgenodeficiencia y salud cardiovascular. Cuadernos de Urología 2009 56; 16-22
20. Daneshgari F., Brown J.S., Kusek J.W., Nyberg L.M. Urological complications of obesity and diabetes. J. Urol. 2009 182; S1-S56 (suplemento)
21. Brenner BM, Cooper ME, De Zeeuw D, Keane WF, Mitch WE, Parving HH, et al.. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345: 861-869
22. González-Juanatey JR, Mazón P, Soria F, Barrios V, Rodríguez L, Bertomeu V.. Actualización (2003) de las Guías de Práctica Clínica de la Sociedad Española de Cardiología en hipertensión arterial. Rev Esp Cardiol. 2003; 56: 487-497
23. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al.. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations in the Anglo-Scandinavian cardiac outcomes trial-lipid lowering arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2004;361:1149-1158
24. Makhsida N, Shah J, Yan G, Fisch H, Shabsigh R. Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol Sep 2005; 174 (03):827-834
25. Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S, Mohanty P. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Curr Mol Med.2008 Dec; 8(8): 816-828
26. Saad F, Gooren L, Haider A, Yassin A. An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome.Arch Androl. 2007 Nov-Dec; 53(6): 353-357
27. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009 Dec; 5(12): 673-681
28. Spark RF. Testosterone, diabetes mellitus, and the metabolic syndrome. Curr Urol Rep. 2007 Nov; 8(6): 467-471
29. Maggio M, Basaria S.Welcoming low testosterone as a cardiovascular risk factor. Int J Impot Res. 2009 Jul-Aug; 21(4): 261-264